This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 900700 Submitted by lobbyist on: January 2, 2019 08:05:28 AM Accepted by Registrar on: January 2, 2019 08:38:28 AM
Designated Filer Information
Matar, Lisa
3650 Danforth Avenue
Toronto, ON, M1N 2E8
416-699-7222
Canada
Organization Information
Eli Lilly Canada Inc.
Eli Lilly is committed to providing answers that matter in medicine, life sciences and health care. As a leading inovation-driven pharmaceutical corporation, Lilly is developing a growing portfolio of products by applying the latest research from its own worldwide laboratories, by collaborating with eminent scientific organizations, by making use of the most up-to-date technological tools and by providing exceptional service to its customers. Headquartered in Indianapolis, Indiana, Lilly provides answers; through medicines and information; for some of the world's most urgent medical needs. Eli Lilly Canada, headquartered in Toronto, Ontario, employs more than 500 people across the country. Additional information about Eli Lilly Canada can be found at www.lilly.ca.
3650 Danforth Avenue
Toronto, ON, M1N 2E8
416-693-3777
Canada
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
January 2, 2019
July 2, 2019
Organization's In-House Lobbyists
Name:
Bayne, Patricia (Trish)
January 2, 2019
Inactivation Date:
July 31, 2019
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan reimbursement and design, and health system design.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Public Agency
Health
January 2, 2019
Name:
Daley, Jill
January 2, 2019
Inactivation Date:
July 31, 2019
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Participation in the consultations being led by the BC Ministry of Health related to the potential development of a Health Sector Payment Transparency Program (HSPTP).
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Public Agency
Health
January 2, 2019
Name:
Fischer, Lauren
January 2, 2019
Inactivation Date:
July 31, 2019
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan reimbursement and design, and health system design.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Public Agency
Health
January 2, 2019
Name:
Khan, Derek
January 2, 2019
Inactivation Date:
July 31, 2019
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Participation in the consultations being led by the BC Ministry of Health related to the potential development of a Health Sector Payment Transparency Program (HSPTP).
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Public Agency
Health
January 2, 2019
Name:
Lanman, Lydia
January 2, 2019
Inactivation Date:
July 31, 2019
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan reimbursement and design, and health system design. Participation in the consultations being led by the BC Ministry of Health related to the potential development of a Health Sector Payment Transparency Program (HSPTP).
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Public Agency
Health
January 2, 2019
Name:
Stewart, Dean
January 2, 2019
Inactivation Date:
July 31, 2019
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Discussions related to Eli Lilly's products in the following therapeutic areas for the purpose of maintaining and/or obtaining public reimbursement in BC: Soft Tissue Sarcoma, Breast Cancer, Gastric Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Diabetes, Human Growth Hormone Deficiency, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Osteoporosis, Migraine, Pain, Chronic Pain, Depression, Erectile Dysfunction, Benign Prostatic Hyperplasia.
